The U.S. Patent and Trademark Office has issued a patent on combination therapies that could treat spinal muscular atrophy. The therapies were created by Dr. Elliot J. Androphy of the Indiana University School of Medicine.
Spinal muscular atrophy is a genetic neurological disorder that results from loss of function of cells in the spinal cord. Symptoms include progressive motor weakness, muscle wasting and paralysis.
The innovation was disclosed to the IU Innovation and Commercialization Office. The mission of the office is to drive innovation to the market for the benefit of the public, the university and innovators for state, national and global commerce. IU personnel can disclose an invention online.